Overview: Luprodex 22.5 mg Leuprolide Acetate Injection contains Leuprolide Acetate (22.5 mg) and is a prescription long-acting hormonal therapy used in the management of prostate cancer, endometriosis and uterine fibroids by suppressing gonadotropin release and reducing testosterone or estrogen levels. Key Benefits: – Provides sustained hormone suppression for prostate cancer and gynecological conditions – Reduces estrogen/testosterone levels to slow disease progression – Long-acting depot formulation for monthly or quarterly dosing Composition: Leuprolide Acetate (22.5 mg) How It Works: Leuprolide Acetate is a gonadotropin-releasing hormone (GnRH) agonist that initially stimulates then down-regulates GnRH receptors in the pituitary, leading to a decrease in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release, which suppresses sex hormone production. Usage Instructions: – Administer only under the supervision of a qualified healthcare professional – Usually given as a deep subcutaneous or intramuscular injection as prescribed – Follow the recommended dosing schedule strictly Side Effects: – Hot flashes, sweating, injection site discomfort – Decreased libido, mood changes – Temporary flare in symptoms at the start of therapy Precautions: – Not recommended during pregnancy or breastfeeding unless clearly advised by a physician – Monitor hormone levels and symptom response during treatment – Inform your doctor of all current medications Storage Instructions: – Store refrigerated between 2-8°C, protect from light, do not freeze Manufacturer: Cipla Ltd Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.